Stockscreener 앱 받기
10.71
1.79%
-0.195
시간 외 거래:
10.72
0.005
+0.05%
Avadel Pharmaceuticals Plc 주식(AVDL)의 최신 뉴스
Short Interest in Avadel Pharmaceuticals plc (NASDAQ:AVDL) Declines By 7.3% - MarketBeat
What is HC Wainwright’s Estimate for AVDL FY2024 Earnings? - Defense World
Idiopathic Hypersomnia Treatment Market will experience - openPR
HC Wainwright Issues Pessimistic Forecast for AVDL Earnings - MarketBeat
What is Lifesci Capital's Forecast for AVDL FY2024 Earnings? - MarketBeat
What is Leerink Partnrs' Forecast for AVDL FY2024 Earnings? - MarketBeat
Avadel Pharmaceuticals plc (AVDL) Outlook: Looking Back For Insights - Stocks Register
Janus Henderson Group's Strategic Acquisition of Avadel Pharmace - GuruFocus.com
FY2025 Earnings Estimate for AVDL Issued By Leerink Partnrs - MarketBeat
Avadel Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance UK
Avadel shares price target cut, maintains buy on Q3 results By Investing.com - Investing.com Nigeria
Polar Capital Holdings Plc's Strategic Reduction in Avadel Pharm - GuruFocus.com
Avadel Pharmaceuticals PLC (AVDL) Shares Down 7.38% on Nov 13 - GuruFocus.com
Avadel Pharmaceuticals (NASDAQ:AVDL) Announces Earnings Results - MarketBeat
Avadel Pharmaceuticals (NASDAQ:AVDL) Stock Price Down 3.9% After Analyst Downgrade - MarketBeat
Avadel Pharmaceuticals (NASDAQ:AVDL) Price Target Lowered to $25.00 at HC Wainwright - MarketBeat
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q3 2024 Earnings Call Transcript - Insider Monkey
Avadel Pharmaceuticals to Present at the Jefferies London Healthcare Conference - The Manila Times
Avadel Pharmaceuticals to Present at Jefferies London Healthcare Conference | AVDL Stock News - StockTitan
Avadel Pharmaceuticals plc (AVDL) Quarterly 10-Q Report - Quartzy
Avadel Pharmaceuticals Reports Strong Growth with LUMRYZ - TipRanks
Avadel: Q3 Earnings Snapshot - Houston Chronicle
Avadel Pharmaceuticals PLC (AVDL) Stock Price Down 15.83% on Nov 12 - GuruFocus.com
Avadel Pharmaceuticals plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Needham & Company LLC Reiterates Buy Rating for Avadel Pharmaceuticals (NASDAQ:AVDL) - MarketBeat
Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2024 Financial Results - The Manila Times
Avadel's LUMRYZ Sales Surge to $50M as Patient Base Grows 44% in Q3 | AVDL Stock News - StockTitan
Avadel Pharmaceuticals PLC (AVDL) Q3 2024: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Learn to Evaluate (AVDL) using the Charts - Stock Traders Daily
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat
Avadel Pharmaceuticals (AVDL) Scheduled to Post Quarterly Earnings on Tuesday - MarketBeat
Avadel Pharmaceuticals to Provide a Corporate Update and Report Third Quarter 2024 Financial Results on November 12 - The Manila Times
Avadel Pharmaceuticals (NASDAQ:AVDL) Earns “Buy” Rating from Needham & Company LLC - Defense World
Oppenheimer Forecasts Strong Price Appreciation for Avadel Pharmaceuticals (NASDAQ:AVDL) Stock - Defense World
Avadel Pharmaceuticals’ (AVDL) “Buy” Rating Reaffirmed at HC Wainwright - Defense World
Court Denies Jazz’s Challenge of Avadel’s Orphan Drug Lumryz - Sleep Review
US court upholds Avadel’s narcolepsy drug approval amid exclusivity battle - Yahoo Finance
Loss-Making Avadel Pharmaceuticals plc (NASDAQ:AVDL) Expected To Breakeven In The Medium-Term - Yahoo Finance
Avadel Pharmaceuticals Sees Unusually High Options Volume (NASDAQ:AVDL) - Defense World
Court upholds FDA approval of Avadel's narcolepsy drug LUMRYZ By Investing.com - Investing.com South Africa
Avadel Pharmaceuticals (NASDAQ:AVDL) Shares Gap UpStill a Buy? - MarketBeat
Court upholds FDA approval of Avadel's narcolepsy drug LUMRYZ - Investing.com
Avadel Pharma Shares Rise on Favorable Ruling for FDA in Lumryz Litigation - Marketscreener.com
Shares Rally Up For Avadel (AVDL) As Court Rules Favorably - Stocks Telegraph
Needham & Company LLC Reiterates "Buy" Rating for Avadel Pharmaceuticals (NASDAQ:AVDL) - MarketBeat
Avadel soars after court rules in favor of FDA in Lumryz case with Jazz Pharma - MSN
Avadel Pharmaceuticals Announces Favorable Ruling in Administrative Procedure Act Litigation - The Manila Times
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Shares Bought by Iridian Asset Management LLC CT - MarketBeat
Trend Tracker for (AVDL) - Stock Traders Daily
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Short Interest Update - MarketBeat
Avadel Obtains FDA Nod for Label Expansion of Narcolepsy Drug Lumryz - MSN
Avadel Pharmaceuticals and nference Announce Publication of Real-World Data in Sleep Advances - StockTitan
Avadel Pharmaceuticals (NASDAQ:AVDL) Stock Rating Reaffirmed by HC Wainwright - Defense World
Avadel Pharmaceuticals' (AVDL) Buy Rating Reiterated at HC Wainwright - MarketBeat
H.C. Wainwright maintains Buy rating on Avadel shares as FDA approves LUMRYZ for pediatrics - Investing.com UK
Needham & Company LLC Reaffirms Buy Rating for Avadel Pharmaceuticals (NASDAQ:AVDL) - Defense World
0.79%
0.15%
자본화:
|
볼륨(24시간):